To identify risk factors of second-line ART treatment failure, variables such as age, duration of follow-up, Advanced WHO clinical stage, ART drug adherence, baseline CD4 count, Body mass index and tuberculosis co-infection were extracted from the included studies. Here, CD4 is linked to tuberculosis.